101 related articles for article (PubMed ID: 19375220)
1. Tumor suppressor protein p53 induces degradation of the oncogenic protein HBx.
Park SG; Min JY; Chung C; Hsieh A; Jung G
Cancer Lett; 2009 Sep; 282(2):229-37. PubMed ID: 19375220
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus X Protein Stabilizes Cyclin D1 and Increases Cyclin D1 Nuclear Accumulation through ERK-Mediated Inactivation of GSK-3β.
Chen X; Zhang L; Zheng S; Zhang T; Li M; Zhang X; Zeng Z; McCrae MA; Zhao J; Zhuang H; Lu F
Cancer Prev Res (Phila); 2015 May; 8(5):455-63. PubMed ID: 25712050
[TBL] [Abstract][Full Text] [Related]
3. Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC.
Knoll S; Fürst K; Thomas S; Villanueva Baselga S; Stoll A; Schaefer S; Pützer BM
Cell Cycle; 2011 Oct; 10(20):3554-65. PubMed ID: 22030623
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein differentially affects the ubiquitin-mediated proteasomal degradation of beta-catenin depending on the status of cellular p53.
Jung JK; Kwun HJ; Lee JO; Arora P; Jang KL
J Gen Virol; 2007 Aug; 88(Pt 8):2144-2154. PubMed ID: 17622616
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells.
Wang W; Zhou D; Wei J; Wu Z; Cheng X; Sun Q; Xie H; Zhou L; Zheng S
Biochem Biophys Res Commun; 2012 May; 421(2):355-60. PubMed ID: 22510407
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.
Chung TW; Lee YC; Ko JH; Kim CH
Cancer Res; 2003 Jul; 63(13):3453-8. PubMed ID: 12839924
[TBL] [Abstract][Full Text] [Related]
8. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.
Cheng AS; Yu J; Lai PB; Chan HL; Sung JJ
Biochem Biophys Res Commun; 2008 Sep; 374(2):175-80. PubMed ID: 18601905
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression.
Yano M; Ohkoshi S; Aoki YH; Takahashi H; Kurita S; Yamazaki K; Suzuki K; Yamagiwa S; Sanpei A; Fujimaki S; Wakai T; Kudo SE; Matsuda Y; Aoyagi Y
Liver Int; 2013 Sep; 33(8):1218-29. PubMed ID: 23590292
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function.
Hsieh JL; Wu CL; Lee CH; Shiau AL
Clin Cancer Res; 2003 Jan; 9(1):338-45. PubMed ID: 12538486
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter.
Park SG; Chung C; Kang H; Kim JY; Jung G
J Biol Chem; 2006 Oct; 281(42):31770-7. PubMed ID: 16940298
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein induces IKKα nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells.
Huang WC; Chen WS; Chen YJ; Wang LY; Hsu SC; Chen CC; Hung MC
J Cell Physiol; 2012 Apr; 227(4):1446-54. PubMed ID: 21618535
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
[TBL] [Abstract][Full Text] [Related]
15. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
[TBL] [Abstract][Full Text] [Related]
16. Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53.
Dewantoro O; Gani RA; Akbar N
Acta Med Indones; 2006; 38(3):154-9. PubMed ID: 16953033
[TBL] [Abstract][Full Text] [Related]
17. Caspase-3 activation as a key factor for HBx-transformed cell death.
Kim A; Kwon OS; Kim SO; He L; Bae EY; Lee MS; Jeong SJ; Shim JH; Yoon DY; Kim CH; Moon A; Kim KE; Ahn JS; Kim BY
Cell Prolif; 2008 Oct; 41(5):755-74. PubMed ID: 18700866
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.
Kongkavitoon P; Tangkijvanich P; Hirankarn N; Palaga T
PLoS One; 2016; 11(1):e0146696. PubMed ID: 26766040
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory cytokine TNF-α increases the stability of hepatitis B virus X protein through NF-κB signaling.
Shukla R; Yue J; Siouda M; Gheit T; Hantz O; Merle P; Zoulim F; Krutovskikh V; Tommasino M; Sylla BS
Carcinogenesis; 2011 Jul; 32(7):978-85. PubMed ID: 21459755
[TBL] [Abstract][Full Text] [Related]
20. Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA.
Kang MS; Lee HJ; Lee JH; Ku JL; Lee KP; Kelley MJ; Won YJ; Kim ST; Park JG
Int J Cancer; 1996 Sep; 67(6):898-902. PubMed ID: 8824565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
